Novo Nordisk A/S
NONOF · OTC
Bulios Fair Price
$49.13
22.8% upside
Current Price
$40.02
According to Bulios Fair Price, NONOF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Novo Nordisk A/S is a Danish pharmaceutical company headquartered in Bagsværd, Denmark, primarily known for its innovative products and treatments for diabetes. Founded in 1923, the company has grown to become a leader in insulin products as well as medications for obesity and other chronic diseases, such as hemophilia and growth disorders. Novo Nordisk operates globally, distributing its products in over 170 countries worldwide.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Maziar Mike Doustdar
Employees
68,794
Headquarters
Bagsvaerd
Upcoming events
Earnings
Upcoming earnings report